94 related articles for article (PubMed ID: 23859481)
41. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
[TBL] [Abstract][Full Text] [Related]
42. 17p anomalies in lymphoid malignancies: diagnostic and prognostic implications.
Schoch C; Rieder H; Stollmann-Gibbels B; Freund M; Tischler HJ; Silling-Engelhardt G; Fonatsch C
Leuk Lymphoma; 1995 Apr; 17(3-4):271-9. PubMed ID: 8580796
[TBL] [Abstract][Full Text] [Related]
43. Cytogenetic complexity and heterogeneity in intravascular lymphoma.
Fujikura K; Yamashita D; Yoshida M; Ishikawa T; Itoh T; Imai Y
J Clin Pathol; 2021 Apr; 74(4):244-250. PubMed ID: 32763919
[TBL] [Abstract][Full Text] [Related]
44. Chromosome 17- and p53 changes in lymphoma.
Rodriguez MA; Ford RJ; Goodacre A; Selvanayagam P; Cabanillas F; Deisseroth AB
Br J Haematol; 1991 Dec; 79(4):575-82. PubMed ID: 1772779
[TBL] [Abstract][Full Text] [Related]
45. Cytogenetic subtyping of diffuse large B-cell lymphomas.
Schlegelberger B
Ann Hematol; 2001; 80 Suppl 3():B32-4. PubMed ID: 11757702
[No Abstract] [Full Text] [Related]
46. Rare Case of Diffuse Large B-Cell Lymphoma Mimicking Acute Monocytic Leukemia, Associated with Complex Karyotype.
Chen X; Liu K; Hu J; Fan J; Huo Q; Yin J
Ann Clin Lab Sci; 2020 May; 50(3):397-400. PubMed ID: 32581033
[TBL] [Abstract][Full Text] [Related]
47. Abnormal chromosomes in histocytic lymphoma.
Goh KO; Herrmann MA
Am J Med Sci; 1984; 288(1):48-52. PubMed ID: 6380292
[TBL] [Abstract][Full Text] [Related]
48. Prognostic implications of cytogenetic aberrations in diffuse large B-cell lymphomas.
Jerkeman M; Johansson B; Akerman M; Cavallin-Ståhl E; Kristoffersson U; Mitelman F
Eur J Haematol; 1999 Mar; 62(3):184-90. PubMed ID: 10089896
[TBL] [Abstract][Full Text] [Related]
49. Tumor protein 53 mutations are enriched in diffuse large B-cell lymphoma with irregular CD19 marker expression.
Kazantseva M; Hung NA; Mehta S; Roth I; Eiholzer R; Rich AM; Seo B; Baird MA; Braithwaite AW; Slatter TL
Sci Rep; 2017 May; 7(1):1566. PubMed ID: 28484276
[TBL] [Abstract][Full Text] [Related]
50. [Frequency, spectrum, and functional significance of TP53 mutations in patients with diffuse large B-cell lymphoma].
Voropaeva EN; Pospelova TI; Voevoda MI; Maksimov VN
Mol Biol (Mosk); 2017; 51(1):64-72. PubMed ID: 28251968
[TBL] [Abstract][Full Text] [Related]
51. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma.
Young KH; Weisenburger DD; Dave BJ; Smith L; Sanger W; Iqbal J; Campo E; Delabie J; Gascoyne RD; Ott G; Rimsza L; Müller-Hermelink HK; Jaffe ES; Rosenwald A; Staudt LM; Chan WC; Greiner TC
Blood; 2007 Dec; 110(13):4396-405. PubMed ID: 17881637
[TBL] [Abstract][Full Text] [Related]
52. Banding studies on chromosomes in diffuse "histiocytic" lymphomas: correlation of 14q+ marker chromosome with cytology.
Fukuhara S; Rowley JD; Variakojis D; Sweet DL
Blood; 1978 Nov; 52(5):989-1002. PubMed ID: 359064
[TBL] [Abstract][Full Text] [Related]
53. Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5
Mishima Y; Terui Y; Yokoyama M; Nishimura N; Ueda K; Kusano Y; Yamauchi H; Inoue N; Takahashi A; Tsuyama N; Mishima Y; Takeuchi K; Hatake K
Br J Haematol; 2018 Nov; 183(4):661-664. PubMed ID: 29076146
[No Abstract] [Full Text] [Related]
54. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma.
Bakhoum SF; Danilova OV; Kaur P; Levy NB; Compton DA
Clin Cancer Res; 2011 Dec; 17(24):7704-11. PubMed ID: 22184286
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive analysis of TP53 mutation characteristics and identification of patients with inferior prognosis and enhanced immune escape in diffuse large B-cell lymphoma.
Zhang T; Lu Y; Liu X; Zhao M; He J; Liu X; Li L; Qiu L; Qian Z; Zhou S; Meng B; Zhai Q; Ren X; Zhang H; Wang X
Am J Hematol; 2022 Jan; 97(1):E14-E17. PubMed ID: 34710245
[No Abstract] [Full Text] [Related]
56. Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma.
Berglund M; Thunberg U; Fridberg M; Wingren AG; Gullbo J; Leuchowius KJ; Amini RM; Lagercrantz S; Horvat A; Enblad G; Söderberg O
Leuk Lymphoma; 2007 May; 48(5):1038-41. PubMed ID: 17487752
[No Abstract] [Full Text] [Related]
57. Diffuse large cell lymphoma presenting as inflammatory bowel disease in an adolescent with ataxia telangiectasia.
Kapoor G; Albrecht RJ; Craver R; Duncan C; Warrier RP
Leuk Res; 1996; 20(11-12):997-8. PubMed ID: 9009261
[No Abstract] [Full Text] [Related]
58. High incidence of 17p13 chromosomal abnormalities in malignant histiocytosis.
Abe R; Akaike Y; Yokoyama A; Shikama Y; Ishibashi T; Mita M; Kimura H; Uchida T; Kariyone S; Wakasa H
Cancer; 1990 Jun; 65(12):2689-96. PubMed ID: 2187586
[TBL] [Abstract][Full Text] [Related]
59. Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma.
Meriranta L; Pasanen A; Louhimo R; Cervera A; Alkodsi A; Autio M; Taskinen M; Rantanen V; Karjalainen-Lindsberg ML; Holte H; Delabie J; Lehtonen R; Hautaniemi S; Leppä S
Haematologica; 2017 May; 102(5):e195-e198. PubMed ID: 28183850
[No Abstract] [Full Text] [Related]
60. Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.
Kato K; Oh Y; Takita J; Gunji Y; Kobayashi C; Yoshimi A; Nakao T; Noma M; Koike K; Morimoto A; Iijima S; Hojo H; Tsuchida M
Int J Hematol; 2016 Feb; 103(2):196-201. PubMed ID: 26676804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
